BibTex RIS Cite

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Year 2013, , 176 - 177, 30.09.2015

Salih Özgüven

https://doi.org/10.5472/MMJ.2013.02828.1

Abstract

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Keywords

-

References

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Year 2013, , 176 - 177, 30.09.2015

Salih Özgüven

https://doi.org/10.5472/MMJ.2013.02828.1

Abstract

-

Keywords

-

References

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.
There are 4 citations in total.

Details

Primary Language English
Journal Section Articles
Authors

Salih Özgüven This is me

Publication Date September 30, 2015
Published in Issue Year 2013

Cite

APA Özgüven, S. (2015). Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal, 26(3), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1
AMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. September 2015;26(3):176-177. doi:10.5472/MMJ.2013.02828.1
Chicago Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26, no. 3 (September 2015): 176-77. https://doi.org/10.5472/MMJ.2013.02828.1.
EndNote Özgüven S (September 1, 2015) Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal 26 3 176–177.
IEEE S. Özgüven, “Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?”, Marmara Med J, vol. 26, no. 3, pp. 176–177, 2015, doi: 10.5472/MMJ.2013.02828.1.
ISNAD Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26/3 (September 2015), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1.
JAMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26:176–177.
MLA Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal, vol. 26, no. 3, 2015, pp. 176-7, doi:10.5472/MMJ.2013.02828.1.
Vancouver Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26(3):176-7.